The Government Pharmaceutical Organisation (GPO) has developed new Aids drugs that are both anti-retroviral formulations containing Dolutegravir and medication to treat complications such as anti-HCV that reduces drug resistance, deputy managing director Sirikul Matevelungsun said on Wednesday.